XClose

UCL Department of Biochemical Engineering

Home
Menu

UCL Cytiva Centre of Excellence (COE)

The UCL-Cytiva Centre of Excellence strategic industrial research programme which started in 2017 is due to run to 2029.

The Centre is worth over £7m, with additional support of £1.6m from the EPSRC Prosperity Partnership, to extend activities to Smart Biomanufacturing for Genomic Medicines. 

UCL Cytiva CoE Group Photo in Quad

 

The COE is dedicated to advancing biomanufacturing through innovative research and cutting-edge technologies. Key areas of focus include:

UCL-Cytiva Infographic: Multiscale Imagoing, Advanced Filtration, Genomic Medicine, Process Monitoring. Cell-free Synthesis, Lipid Nanoparticles
  • Multiscale Imaging: Developing cutting-edge techniques for detailed material visualisation.
  • Advanced Filtration: Enhancing bioprocessing with direct flow and tangential flow filtration technologies.
  • Genomic Medicine: Pioneering new manufacturing methods for genome editing and advanced therapeutics.
  • Process Monitoring: Implementing real-time systems to improve efficiency and maintain consistency in biomanufacturing.
  • Cell-Free Synthesis: Innovating cell-free technologies for DNA and RNA synthesis.
  • Lipid Nanoparticles: Creating advanced drug delivery systems using lipid nanoparticle formulations.

The research centre was setup to foster innovation, facilitate knowledge transfer, and address critical bioprocessing industrial challenges. The CoE has already yielded significant outcomes for both partners, and the new CoE will continue in its mission in bringing together leading key experts from both organizations. The new activity in "Smart Biomanufacturing for Genomic Medicines," aims to address the challenges of manufacturing revolutionary genomic medicines. These therapies hold the potential to transform medical treatments by delivering genetic molecules directly to disease sites, enabling precise control of protein production within cells and tissues. The partnership will improve patient access to these transformative therapies and establish manufacturing innovation in a high-growth sector that will result in societal and economic impact

Publications

Find out more